Phase 1 Study Of Tg-1701, A Selective Irreversible Inhibitor Of Bruton'S Tyrosine Kinase (Btk), In Patients With Relapsed/Refractory B-Cell Malignancies
BLOOD(2019)
Abstract
Introduction
MoreTranslated text
Key words
BTK Inhibitors,Transition State Analogue Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined